Peptide Libraray

Sequence 10 from Patent US 20060122119

General Information

DCTPep ID DCTPep01259

Peptide Name Sequence 10 from Patent US 20060122119

Sequence EAAGIGILY

Sequence Length 9

UniProt ID Not available

PubChem CID Not available

Origin Synthetic construct

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Not available

Disulfide/Other Bond Not available

N-terminal Modification Not available

C-terminal Modification Not available

Other Modification None

Chiral L

Physicochemical Information

Formula C42H67N9O13

Absent amino acids CDFHKMNPQRSTVW

Theoretical pI 4.00

Acidic residues 1

Basic residues 0

Polar residues 3

Molecular weight (Average) 906.05

Molecular weight (Monoisotopic) 905.49

Common amino acids AGI

Net charge -1

Instability index (II) 11.42

Aliphatic index 152.22

Grand average of hydropathicity (GRAVY) 1.200

Half Life
1 hours (mammalian reticulocytes, in vitro).
30 min (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 1.645

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID US 2006/0122119 A1

Patent Title Peptides for use in antitumor immunotherapy.

Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002

Other Published ID CA2477762A1 EP1481009A2 WO2003074565A2 WO2003074565A3